GLP-1 weight loss claims on TikTok: separating fact from hype

What did @charitykface actually say?

Nothing about GLP-1 medications. At all. The transcript is song lyrics, likely from a recorded or lip-synced track. Lines like "the way we always said, forever" and "where no fan would go" are not weight loss claims, dosing instructions, or testimonials about semaglutide. There is simply no medical content here to fact-check.

The video is categorized under GLP-1 receptor agonists, which covers drugs like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide, and retatrutide. That categorization may reflect a platform tag, an account theme, or a filing error. Either way, the lyrics themselves contain zero health claims.

Does the science back this up?

There is no scientific claim in this video to evaluate. The lyrics do not reference appetite suppression, blood glucose control, weight loss percentages, or any mechanism of action. So there is nothing to confirm or contradict with clinical data.

That said, since this video lives in GLP-1 content space, it is worth stating plainly what the research actually shows on these medications. Semaglutide 2.4mg (Wegovy) produced mean body weight reductions of approximately 14.9% over 68 weeks in the STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine). Tirzepatide demonstrated up to 20.9% body weight reduction at the highest dose in the SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine). These are real results from large randomized trials, but they apply to specific approved formulations, not compounded versions, and results vary significantly by individual.

What did they get wrong (or right)?

There is nothing to grade here. The creator did not make a factual claim, a health recommendation, or a product comparison. Singing, or lip-syncing, a song about love and loss is not misinformation.

What is mildly worth noting is the context mismatch. Viewers landing on this video through GLP-1 hashtags or account browsing might expect health content and find lyrics instead. That is not dangerous, but it is not informative either. The video does not spread misinformation about compounded semaglutide versus brand-name products. It does not recommend unsafe medication combinations. It does not suggest a drug cures a disease. By those standards, it is the cleanest video in this category.

What should you actually know?

Since you are here reading a GLP-1 fact-check, here is what actually matters if you are considering these medications.

• GLP-1 receptor agonists work by mimicking a gut hormone that signals fullness and slows gastric emptying. They are not stimulants or appetite suppressants in the traditional sense.
• Compounded semaglutide is not the same as FDA-approved Wegovy or Ozempic. Compounded versions are not tested for bioequivalence by the FDA. Do not assume they perform identically.
• Common side effects include nausea, vomiting, and constipation, particularly during dose escalation. The SCALE and STEP trials both documented gastrointestinal events as the leading reason for discontinuation.
• These medications require a legitimate clinical evaluation before prescribing. Any platform offering them without a real consultation is cutting corners that matter.
• Weight regain after stopping GLP-1 therapy is well-documented. Wilding et al. (2022, Diabetes, Obesity and Metabolism) found participants regained two-thirds of lost weight within one year of discontinuation.

Bottom line

This video is a song. It contains no health claims, accurate or otherwise. If you found this fact-check while researching GLP-1 medications, use that energy to read the actual trial data or talk to a licensed clinician. The STEP and SURMOUNT trial publications are publicly accessible and worth your time far more than any TikTok, including this one.